Filings

1 document · 1 match

1. INTI Inhibitor Therapeutics, Inc. 10-K 2026-03-26

   Item 9A. Controls and Procedures.

   material weaknesses but does acknowledge a significant deficiency in the number of personnel available to serve the Company’s accounting
   1 match in this document Show context Copy citation